K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More